Fulvestrant
NDC 62332-650, Fulvestrant, injection, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-650
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215077
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62332-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-650-10 | 62332065010 | 2 SYRINGE in 1 CARTON (62332-650-10) / 5 mL in 1 SYRINGE (62332-650-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b02915fe-6c44-48c1-aaeb-997ddc59a595Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=62332-650
Use it
Look up 62332-650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.